NICE recommends phased roll out of genetic testing for clopidogrel prescribing
The Pharmaceutical Journal from the Royal Pharmaceutical Society
Source: pharmaceutical-journal.com
Stay updated with breaking news from Genomadix Cube. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Pharmaceutical Journal from the Royal Pharmaceutical Society
The Pharmaceutical Journal from the Royal Pharmaceutical Society
The National Institute for Health and Care Excellence has issued new guidance on drugs which can prevent future attacks.
Clopidogrel is less effective at preventing subsequent strokes in patients with certain variations in the CYP2C19 gene and testing could aid treatment selection.
The National Institute for Health and Care Excellence has issued new guidance on drugs which can prevent future attacks.